Jim advises health care clients on matters involving regulatory compliance (including fraud and abuse, licensure, health privacy and reimbursement issues), structuring of business transactions, corporate governance and tax-exempt status issues. He is a member of the firm’s Health Care Reform Initiative and Pro Bono Committee. Prior to law school, he served as a business development analyst for National Nephrology Associates, a privately held dialysis company is Nashville, TN, where he was responsible for market research, financial analysis and due diligence on the acquisition of 28 dialysis clinics with more than $90 million in net revenues.